Skip to Content

Clinical Trials

Last Updated: 09/07/2010

Untreated

  • Indolent Lymphoma
  • Intermediate/High Grade Lymphoma
  • Hodgkin's Lymphoma
  • Mantle Cell Lymphoma
  • Peripheral T-Cell Lymphoma
  • Multiple Myeloma

Prior Treated

  • Indolent Lymphoma
  • Intermediate Grade Lymphoma
  • Hodgkin Lymphoma
  • Mantle Cell Lymphoma
  • Peripheral T-Cell Lymphoma
  • Multiple Myeloma
  • Phase I Agents

Supportive Care
Previous Post-Allo Transplant

Untreated

Indolent Lymphoma

Intermediate/High Grade Lymphoma

  • R-HCVAD alternating with /R-Methotrexate-Cytarabine vs R-CHOP (2005-0054)
  • RAD001 (2009-0793)

Hodgkin's Lymphoma

Mantle Cell Lymphoma

  • Bortezomib + R-HyperCVAD alternating with Bortezomib+ R-High dose Methotrexate/Cytarabine (2006-0697)

Peripheral T-Cell Lymphoma

Multiple Myeloma/Waldenstrom’s

  • Bortezomib, CNTO328, Melphalan, Prednisone (2009-0113)
  • Bortezomib, Lenalidomide, Dexamethasone, Vorinostat (2008-0794)
  • Bortezomib, Lenalidomide, Dexamethasone (SWOG SO0777)
  • Siltuximab (2010-0623)

Prior Treatment

Indolent Lymphoma

Intermediate Grade Lymphoma

Hodgkin's Lymphoma

  • SB1518 (2008-0105)
  • HCD 122 (2008-0062)
  • Bortezomib, ICE (2008-0604)
  • Panobinostat, ICE (2010-0065)
  • Brentuximab vedotin (2010-0453)
  • Entinostat (2008-0769)
  • MK-2206 (2010-0261)
  • Panobinostat, Everolimus (2008-0805)
  • RAD001 (2010-0228)
  • SB1518 (2010-0492)
  • AFM13 (2010-0399)
  • SGN-35 (2009-0130)
  • MLN4924 (2008-0135)

Mantle Cell Lymphoma

  • SB1518 (2008-0105)
  • MLN8237 (2008-0278)
  • Bortezomib, Cyclosphosphamide, Rituximab (2009-0057)
  • RAD001 (2008-0436)
  • Panobinostat, Everolimus (2008-0805)
  • MK-2206 (2010-0261)
  • PCI-32765 (2008-0494)
  • MLN4924 (2008-0135)
  • MEDI-551 (2010-0181)
  • SB1518 (2010-0492)

Peripheral T-cell Lymphoma

Multiple Myeloma/Waldenstrom's

  • Carfilzomib, Bortezomib, Dexamethasone (2010-0416)
  • Lenalidomide, Dexamethasone, Panobinostat (2010-0323)
  • Lenalidomide, Dexamethasone, Panobinostat (2010-0398)
  • ARRY-520 (2008-0500)
  • Dexamethesone, Lenalidomide, Thalidomide (2009-0179)
  • MLN9708 (2009-0355)
  • MLN4924 (2008-0135)
  • Bortezomib, KW2478 (2009-0902)
  • hLL1-DOX (2010-0295)

Phase I Agents

Supportive Care

  • Acupuncture (2006-0679)
  • Minocycline (2006-0022)

WaldenstrÖm's Macroglobulinemia

  • Bortezomib, Rituxan (2007-0716)
  • RAD001 (2009-0755)
  • Pomalidomide (2009-0972)
  • Asymptomatic Waldenstrom (2009-0466)

Patients Who Previously Received Post Allo Transplant


© 2010 The University of Texas MD Anderson Cancer Center